CIS is First in the Capital Region to Use the AGENT™ Drug-Coated Balloon to Treat Coronary In-Stent Restenosis

ZACHARY, LA – Dr. Abdullah Munir, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in the Capital Region and second in Louisiana to use the AGENT™ Drug-Coated Balloon, the first FDA-approved drug-coated coronary balloon in the U.S. for the treatment of coronary in-stent restenosis. The procedure took place at Lane Regional Medical Center.

In-stent restenosis (ISR) occurs when a previously stented artery becomes re-narrowed or blocked by scar tissue or plaque. Manufactured by Boston Scientific, the AGENT™ Drug-Coated Balloon (DCB) transfers a therapeutic dose of paclitaxel to the coronary artery wall to help prevent ISR reoccurrence.

“This new technology enables us to help prevent future blockages of the stented coronary artery, without leaving behind another layer of permanent metal implants,” said Dr. Munir.

Learn more about coronary artery disease here.